146062-65-9

Upstream product

• 146062-64-8 5-hydroxymethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 34107-46-5 6-methyl-3-pyridinemethanol 
• 5470-70-2 Methyl 6-methylnicotinate 
• 146062-61-5 3-((methoxymethoxy)methyl)-6-methylpyridine 
• 146062-63-7 5-methoxymethoxymethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 

Downstream Products

• 146062-66-0 5-cyanomethyl-2-<2-(4-nitrophenoxy)ethyl>pyridine 
• 146062-48-8 (+/-)-5-benzyl>-2,4-thiazolinedione 
• 146062-68-2 5-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>benzyl>-2-imino-4-thiazolidinone 
• 146062-67-1 methyl 2-bromo-3-<4-<2-(5-cyanomethyl-2-pyridyl)ethoxy>phenyl>propionate 
• 1026751-32-5 {6-[2-(4-Amino-phenoxy)-ethyl]-pyridin-3-yl}-acetonitrile 

Relevant academic research and scientific papers

Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (±)-5-[p-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone)

The metabolites of (±)-5-[p-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (1, pioglitazone), which is a representative insulin- sensitizing agent, were synthesized to confirm their structures and for studies of their pharmacological properti

Thiazolidinedione derivatives, production and use thereof

A thiazolidinedione compound of the formula STR1 wherein X,Q are as defined in the specification. The compounds are used for treating diabetes.